Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

FR901228 in Treating Patients With Relapsed or Refractory Multiple Myeloma

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
National Cancer Institute (NCI)
ClinicalTrials.gov Identifier:
NCT00066638
First received: August 6, 2003
Last updated: March 16, 2015
Last verified: December 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2011
  Primary Completion Date: May 2007 (Final data collection date for primary outcome measure)